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A B S T R A C T
Background
Women with a suspected large-for-dates fetus or a fetus with suspected macrosomia (birthweight greater than 4000 g) are at risk of
operative birth or caesarean section. The baby is also at increased risk of shoulder dystocia and trauma, in particular fractures and
brachial plexus injury. Induction of labour may reduce these risks by decreasing the birthweight, but may also lead to longer labours
and an increased risk of caesarean section.
Objectives
To assess the effects of a policy of labour induction at or shortly before term (37 to 40 weeks) for suspected fetal macrosomia on the
way of giving birth and maternal or perinatal morbidity.
Search methods
We searched the Cochrane Pregnancy and Childbirth Group’s Trials Register (31 January 2016), contacted trial authors and searched
reference lists of retrieved studies.
Selection criteria
Randomised trials of induction of labour for suspected fetal macrosomia.
Data collection and analysis
Review authors independently assessed trials for inclusion and risk of bias, extracted data and checked them for accuracy. We contacted
study authors for additional information. For key outcomes the quality of the evidence was assessed using the GRADE approach.
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Main results
We included four trials, involving 1190 women. It was not possible to blind women and staff to the intervention, but for other ’Risk
of bias’ domains these studies were assessed as being at low or unclear risk of bias.
Compared to expectant management, there was no clear effect of induction of labour for suspected macrosomia on the risk of caesarean
section (risk ratio (RR) 0.91, 95% confidence interval (CI) 0.76 to 1.09; 1190 women; four trials, moderate-quality evidence) or
instrumental delivery (RR 0.86, 95% CI 0.65 to 1.13; 1190 women; four trials, low-quality evidence). Shoulder dystocia (RR 0.60,
95% CI 0.37 to 0.98; 1190 women; four trials, moderate-quality evidence), and fracture (any) (RR 0.20, 95% CI 0.05 to 0.79; 1190
women; four studies, high-quality evidence) were reduced in the induction of labour group. There were no clear differences between
groups for brachial plexus injury (two events were reported in the control group in one trial, low-quality evidence). There was no
strong evidence of any difference between groups for measures of neonatal asphyxia; low five-minute infant Apgar scores (less than
seven) or low arterial cord blood pH (RR 1.51, 95% CI 0.25 to 9.02; 858 infants; two trials, low-quality evidence; and, RR 1.01,
95% CI 0.46 to 2.22; 818 infants; one trial, moderate-quality evidence, respectively).
Mean birthweight was lower in the induction group, but there was considerable heterogeneity between studies for this outcome (mean
difference (MD) -178.03 g, 95% CI -315.26 to -40.81; 1190 infants; four studies; I2 = 89%). In one study with data for 818 women,
third- and fourth-degree perineal tears were increased in the induction group (RR 3.70, 95% CI 1.04 to 13.17).
For outcomes assessed using GRADE, we based our downgrading decisions on high risk of bias from lack of blinding and imprecision
of effect estimates.
Authors’ conclusions
Induction of labour for suspected fetal macrosomia has not been shown to alter the risk of brachial plexus injury, but the power of the
included studies to show a difference for such a rare event is limited. Also antenatal estimates of fetal weight are often inaccurate so
many women may be worried unnecessarily, and many inductions may not be needed. Nevertheless, induction of labour for suspected
fetal macrosomia results in a lower mean birthweight, and fewer birth fractures and shoulder dystocia. The unexpected observation
in the induction group of increased perineal damage, and the plausible, but of uncertain significance, observation of increased use of
phototherapy, both in the largest trial, should also be kept in mind.
Findings from trials included in the review suggest that to prevent one fracture it would be necessary to induce labour in 60 women.
Since induction of labour does not appear to alter the rate of caesarean delivery or instrumental delivery, it is likely to be popular with
many women. In settings where obstetricians can be reasonably confident about their scan assessment of fetal weight, the advantages
and disadvantages of induction at or near term for fetuses suspected of being macrosomic should be discussed with parents.
Although some parents and doctors may feel the evidence already justifies induction, others may justifiably disagree. Further trials
of induction shortly before term for suspected fetal macrosomia are needed. Such trials should concentrate on refining the optimum
gestation of induction, and improving the accuracy of the diagnosis of macrosomia.
P L A I N L A N G U A G E S U M M A R Y
Induction of labour at or near the end of pregnancy for babies suspected of being very large (macrosomia)
What is the issue?
Babies who are very large (or macrosomic, weighing over 4000 g when born) can have difficult and occasionally traumatic births. One
suggestion to try to reduce this trauma has been to induce labour early, before the baby grows too big. The estimation of the baby’s
weight is difficult before birth and not very accurate. Clinical estimations are based on feeling the uterus and measuring the height of
the fundus of the uterus. Both are subject to considerable variation. Ultrasound scanning is also not accurate, so suspected large babies
may not be confirmed at delivery. This may worry parents.
Why is this important?
If undertaken too early, induction of labour can lead to babies being born prematurely and with immature organs.
What evidence did we find?
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We found four trials that assessed induction of labour at 37 to 40 weeks for women when it was suspected that their baby was large.
A total of 1190 pregnant, non-diabetic women were involved. We searched for evidence on 31 October 2015. The studies were of
moderate or good quality although it was not possible to blind the women and staff providing care to which group women had been
assigned. This may have introduced bias.
What does this mean?
The number of births where the baby’s shoulder became stuck (shoulder dystocia) or a bone was fractured (usually the clavicle, which
heals well without consequences) were reduced in the induction of labour group. The evidence was assessed as moderate quality for
shoulder dystocia and high quality for fracture. No clear differences between groups were reported for damage to the network of nerves
that send signals from the spine to the shoulder, arm and hand (brachial plexus injury) of the baby (low-quality evidence due to very
few events occurring) or signs of not enough oxygen during birth. A policy of labour induction reduced the average birthweight of
babies by 178 g. The trials did not show any differences in the number of women who had caesarean sections or instrumental births.
There is limited evidence that more women in the induction of labour group had severe damage to the perineum. We conclude that
there appear to be benefits, but there may also be some disadvantages of induction of labour shortly before term. The option of having
an induction should be discussed with parents when their baby is suspected to be extra large.
Although some parents and doctors may feel the existing evidence is sufficient to justify inducing labour, others may disagree. Further
high-quality studies are needed in order to find out what is the best time to induce labour towards the end of pregnancy, and how to
improve the accuracy in diagnosing macrosomia.
A visual summary of some of the results from this review can be found here (screen view version) and (printable version here).
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Induct ion of labour versus expectant management for suspected fetal macrosomia
Patient or population: women with term or near term (> 37 weeks’ gestat ion) with suspected fetal macrosomia
Setting: data f rom four trials: a mult i-centre study in France, Belgium and Switzerland and studies in UK, Israel and USA
Intervention: induct ion of labour
Comparison: expectant management
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Risk with expectant man-
agement
Risk with Induction
Caesarean sect ion Study populat ion RR 0.91
(0.76 to 1.09)
1190
(4 RCTs)
⊕⊕⊕©
MODERATE 1
293 per 1000 267 per 1000
(223 to 320)
Moderate
296 per 1000 269 per 1000
(225 to 323)
Instrumental delivery Study populat ion RR 0.86
(0.65 to 1.13)
1190
(4 RCTs)
⊕⊕©©
LOW 12
152 per 1000 130 per 1000
(99 to 171)
Moderate
148 per 1000 127 per 1000
(96 to 167)
Shoulder dystocia Study populat ion RR 0.60
(0.37 to 0.98)
1190
(4 RCTs)
⊕⊕⊕©
MODERATE 13
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68 per 1000 41 per 1000
(25 to 67)
Moderate
61 per 1000 36 per 1000
(22 to 59)
Brachial plexus injury Study populat ion RR 0.21
(0.01 to 4.28)
1190
(4 RCTs)
⊕⊕©©
LOW 4
3 per 1000 1 per 1000
(0 to 14)
Fracture (any) Study populat ion RR 0.20
(0.05 to 0.79)
1190
(4 RCTs)
⊕⊕⊕⊕
HIGH 5
20 per 1000 4 per 1000
(1 to 16)
Moderate
10 per 1000 2 per 1000
(0 to 8)
Low Apgar score (5 min-
utes)
Study populat ion RR 1.51
(0.25 to 9.02)
858
(2 RCTs)
⊕⊕©©
LOW 4
5 per 1000 7 per 1000
(1 to 42)
Moderate
2 per 1000 4 per 1000
(1 to 22)
Low arterial cord blood pH
(< 7.10)
Study populat ion RR 1.01
(0.46 to 2.22)
818
(1 RCT)
⊕⊕⊕©
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29 per 1000 29 per 1000
(13 to 65)
Moderate
29 per 1000 29 per 1000
(13 to 65)
* The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95% CI).
CI: Conf idence interval; RR: Risk rat io; OR: Odds rat io;
GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
M oderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1 Studies contribut ing data were at risk of bias (lack of blinding)
2 Wide 95% CI crossing the line of no ef fect
3 We downgraded this outcome for lack of blinding (clinical assessment of dystocia could be af fected by lack of blinding)
4 Wide 95% CI crossing the line of no ef fect and low event rate
5 Not downgraded for low event rates due to fairly large sample, and 95% CI not crossing the line of no ef fect, and we
considered this outcome was less likely to be af fected by lack of blinding
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B A C K G R O U N D
Description of the condition
Macrosomia is usually defined as a birthweight above 4000 g,
although sometimes a higher cut-off is used (4500 g) (Delpapa
1991; Chatfield 2001: Ju 2009). Large-for-gestational-age fetuses
are usually defined as those with a birthweight above the 90th per-
centile. Approximately 10% of pregnancies are affected by macro-
somia, although estimates range from 3% to 15% in different set-
tings (Chatfield 2001; Mohammadbeigi 2013).
Risk factors for giving birth to a large birthweight infant include a
previous history ofmacrosomia,maternal obesity,maternal weight
gain during pregnancy, multiparity and male fetus (Berard 1998;
Cameron 2014; Gaudet 2014).
Macrosomia is associated with a prolonged labour and mater-
nal trauma along with a higher risk of birth injuries for the in-
fant and longer-term adverse consequences (Ju 2009; Chatfield
2001; Mohammadbeigi 2013; Perlow 1996). Women with large-
for-dates fetuses are more likely to have labour augmentation and
caesarean section, more serious perineal trauma, and more severe
morbidity. High birthweight babies are at higher risk of sustain-
ing injuries at the birth; risks of shoulder dystocia, fracture and
brachial plexus injury are increased. There is an increased risk of
fetal death and neonatal complications, and the risks of diabetes
and cardiovascular disease in childhood and adult life are also el-
evated.
Description of the intervention
Before caesarean section became reasonably safe, induction of
labour for suspected macrosomia was performed because it was
thought to prevent severe cephalo-pelvic disproportion and its as-
sociated maternal mortality and severe morbidity (Thiery 1989).
Nowadays, some obstetricians induce labour at term when the
fetus is estimated to be either large-for-gestational age or macro-
somic.
How the intervention might work
The purpose of labour induction at or shortly before term (37
to 40 weeks) in case of suspected fetal macrosomia is to reduce
the likelihood of a difficult birth, possibly resulting in maternal
or perinatal morbidity (Perlow 1996). In particular, the risk of
shoulder dystocia and the associated risk of neonatal traumamight
be reduced by the intervention. Observational studies cast doubts
on the effectiveness of such a policy (Friesen 1995; Weeks 1995),
and have suggested that induction increases the risk of caesarean
section without reducing birth injury.
Weighing the infant after the birth is the only accurate way to
identify macrosomia. For a policy of induction to be effective,
large-for-gestational-age fetuses must be reliably identified before
they become macrosomic. Estimation of the fetal weight is diffi-
cult. Clinical estimation based on manual palpation of the uterus
or uterine height measurements, as well as ultrasound scanning,
is a method currently used to attempt to predict the fetal weight.
The predictive value of such tests, especially for large fetuses, is
poor (Coomarasamy 2005; Johnstone 1997).MagneticResonance
Imaging (MRI) may be a more accurate method for estimating
fetal weight, but at present the evidence for this is limited (Malin
2016). The accuracy of fetal weight estimation may be one of the
limitations of a policy of induction of labour for suspected macro-
somia.
Why it is important to do this review
In cases of suspected fetal macrosomia, it has not been clear
whether a policy of induction of labour affects the risk of having
caesarean section, instrumental birth, or perineal trauma, or im-
proves outcomes for babies. The purpose of the review is to com-
pare outcomes in women and infants where induction of labour
has been compared with expectant management in randomised
controlled trials. The review will be useful to guide clinical deci-
sions and to allow women to make more informed choices about
their care in cases of suspected large-for-dates fetus.
O B J E C T I V E S
To evaluate a policy of labour induction for suspected fetal macro-
somia on the risk of caesarean section, instrumental delivery and
perineal trauma.
To evaluate a policy of labour induction for suspected fetal macro-
somia on the risk of shoulder dystocia, birth trauma or asphyxia,
and infant morbidity.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included all known randomised controlled trials evaluating
labour induction for suspected fetal macrosomia. We planned
to include cluster-randomised trials if any were identified. We
planned to exclude quasi-randomised trials and studies using a
cross-over design; the latter type of study is not an appropriate
design for this type of intervention.
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Types of participants
Term (37 to 40 weeks’ gestation) pregnant women bearing a fetus
suspected to be macrosomic and without other indications for
induction of labour.
Types of interventions
We considered studies comparing induction of labour with expec-
tant management for inclusion in this review.
Types of outcome measures
Primary outcomes
Maternal outcomes
• Caesarean section
• Instrumental delivery
Perinatal outcomes
• Shoulder dystocia
• Brachial plexus injury
• Fracture (any)
• Neonatal asphyxia (low arterial cord blood pH, or low five-
minute Apgar score
Secondary outcomes
Maternal outcomes
• Spontaneous delivery
• Third- and fourth-degree perineal tears
• Maternal dissatisfaction (pain, sexual dysfunction)
Perinatal outcomes
• Mean birthweight (g)
• Admission to neonatal intensive care unit
• Intracranial haemorrhage
• Convulsions
• Perinatal mortality
• Long-term disability in childhood
In this version of the review we have also reported findings for the
following non pre-specified outcomes.
• Significant shoulder dystocia (trialist defined)
• Serious neonatal morbidity or death (composite outcome)
• Use of phototherapy
• Cephalohematoma
Search methods for identification of studies
The followingmethods section of this review is based on a standard
template used by the Cochrane Pregnancy and Childbirth Group.
Electronic searches
We searched the Cochrane Pregnancy and Childbirth Group’s Tri-
als Register by contacting the Trials Search Co-ordinator (31 Jan-
uary 2016).
The Register is a database containing over 20,000 reports of con-
trolled trials in the field of pregnancy and childbirth. For full
search methods used to populate the Pregnancy and Childbirth
Group’s Trials Register including the detailed search strategies for
CENTRAL, MEDLINE, Embase and CINAHL; the list of hand-
searched journals and conference proceedings, and the list of jour-
nals reviewed via the current awareness service, please follow this
link to the editorial information about the Cochrane Pregnancy
and Childbirth Group inThe Cochrane Library and select the ‘Spe-
cialized Register ’ section from the options on the left side of the
screen.
Briefly, the Cochrane Pregnancy and Childbirth Group’s Trials
Register is maintained by the Trials Search Co-ordinator and con-
tains trials identified from:
1. monthly searches of the Cochrane Central Register of
Controlled Trials (CENTRAL);
2. weekly searches of MEDLINE (Ovid);
3. weekly searches of Embase (Ovid);
4. monthly searches of CINAHL (EBSCO);
5. handsearches of 30 journals and the proceedings of major
conferences;
6. weekly current awareness alerts for a further 44 journals
plus monthly BioMed Central email alerts.
Search results are screened by two people and the full text of all
relevant trial reports identified through the searching activities de-
scribed above is reviewed. Based on the intervention described,
each trial report is assigned a number that corresponds to a spe-
cific Pregnancy and Childbirth Group review topic (or topics),
and is then added to the Register. The Trials Search Co-ordina-
tor searches the Register for each review using this topic number
rather than keywords. This results in a more specific search set
which has been fully accounted for in the relevant review sections
(Included and Ongoing studies).
Searching other resources
We searched the reference lists of retrieved studies and contacted
trial authors for unpublished data.
We did not apply any language or date restrictions.
Data collection and analysis
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For methods used in the previous version of this review, see Irion
1998.
For this update, we used the followingmethods, which are based on
a standard template used by the Cochrane Pregnancy and Child-
birth Group.
Selection of studies
Two review authors independently assessed for inclusion all the
potential studies identified as a result of the search strategy. We
resolved any disagreement through discussion.
Data extraction and management
We designed a form to extract data. For eligible studies, two re-
view authors extracted the data using the agreed form. We re-
solved discrepancies through discussion. Data were entered into
Review Manager software (RevMan 2014) and checked for accu-
racy. Three of the review authors (MB, OI and JT) were inves-
tigators on trials included in the review; these authors were not
involved in data extraction or assessing risk of bias for their trials.
When information regarding any of the above was unclear, we
planned to contact authors of the original reports to provide fur-
ther details.
Assessment of risk of bias in included studies
Two review authors independently assessed risk of bias for each
study using the criteria outlined in the Cochrane Handbook for Sys-
tematic Reviews of Interventions (Higgins 2011). Any disagreement
was resolved by discussion or by involving a third assessor.
(1) Random sequence generation (checking for possible
selection bias)
We described for each included study the method used to generate
the allocation sequence in sufficient detail to allow an assessment
of whether it should produce comparable groups.
We assessed the method as:
• low risk of bias (any truly random process, e.g. random
number table; computer random number generator);
• high risk of bias (any non-random process, e.g. odd or even
date of birth; hospital or clinic record number);
• unclear risk of bias.
(2) Allocation concealment (checking for possible selection
bias)
We described for each included study the method used to con-
ceal allocation to interventions prior to assignment and assessed
whether intervention allocation could have been foreseen in ad-
vance of, or during recruitment, or changed after assignment.
We assessed the methods as:
• low risk of bias (e.g. web or telephone randomisation;
consecutively numbered sealed opaque envelopes);
• high risk of bias (open list of random allocation; unsealed
or non-opaque envelopes, alternation; date of birth);
• unclear risk of bias.
(3.1) Blinding of participants and personnel (checking for
possible performance bias)
Blinding of staff or women to this type of intervention is not feasi-
ble. However, for each outcome we were able to consider whether
lack of blinding was likely to affect results.
(3.2) Blinding of outcome assessment (checking for possible
detection bias)
We described for each included study the methods used, if any, to
blind outcome assessors from knowledge of which intervention a
participant received. We assessed blinding separately for different
outcomes or classes of outcomes.
We assessed methods used to blind outcome assessment as:
• low, high or unclear risk of bias.
(4) Incomplete outcome data (checking for possible attrition
bias due to the amount, nature and handling of incomplete
outcome data)
We described for each included study, and for each outcome or
class of outcomes, the completeness of data including attrition and
exclusions from the analysis. We stated whether attrition and ex-
clusions were reported and the numbers included in the analysis at
each stage (compared with the total randomised participants), rea-
sons for attrition or exclusion where reported, and whether miss-
ing data were balanced across groups or were related to outcomes.
Where sufficient information was reported, or could be supplied
by the trial authors, we planned to re-include missing data in the
analyses which we undertook.
We assessed methods as:
• low risk of bias (e.g. no missing outcome data; missing
outcome data balanced across groups);
• high risk of bias (e.g. numbers or reasons for missing data
imbalanced across groups; ‘as treated’ analysis done with
substantial departure of intervention received from that assigned
at randomisation);
• unclear risk of bias.
(5) Selective reporting (checking for reporting bias)
We described for each included study how we investigated the
possibility of selective outcome reporting bias and what we found.
We assessed the methods as:
• low risk of bias (where it is clear that all of the study’s pre-
specified outcomes and all expected outcomes of interest to the
review have been reported);
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• high risk of bias (where not all the study’s pre-specified
outcomes have been reported; one or more reported primary
outcomes were not pre-specified; outcomes of interest are
reported incompletely and so cannot be used; study fails to
include results of a key outcome that would have been expected
to have been reported);
• unclear risk of bias.
(6) Other bias (checking for bias due to problems not
covered by (1) to (5) above)
We described for each included study any important concerns we
had about other possible sources of bias.
(7) Overall risk of bias
We made explicit judgements about whether studies were at high
risk of bias, according to the criteria given in the Handbook (
Higgins 2011). With reference to (1) to (6) above, we planned to
assess the likely magnitude and direction of the bias and whether
we considered it is likely to impact on the findings. In future
updates, if more data become available, we will explore the impact
of the level of bias through undertaking sensitivity analyses - see
Sensitivity analysis.
Assessing the quality of the body of evidence using
the GRADE approach
For this update the quality of the evidence has been evaluated using
the GRADE approach as outlined in the GRADE Handbook in
order to assess the quality of the body of evidence relating to the
following outcomes.
Maternal outcomes
• Caesarean section
• Instrumental delivery
Perinatal outcomes
• Shoulder dystocia
• Brachial plexus injury
• Fracture (any)
• Neonatal asphyxia (low arterial cord blood pH, or low five-
minute Apgar score)
We used the GRADEpro Guideline Development Tool to import
data from Review Manager 5.3 (RevMan 2014) in order to create
a ’Summary of findings’ table. A summary of the intervention
effect and a measure of quality for each of the above outcomes was
produced using the GRADE approach. The GRADE approach
uses five considerations (study limitations, consistency of effect,
imprecision, indirectness and publication bias) to assess the quality
of the body of evidence for each outcome. The evidence can be
downgraded from ’high quality’ by one level for serious (or by
two levels for very serious) limitations, depending on assessments
for risk of bias, indirectness of evidence, serious inconsistency,
imprecision of effect estimates or potential publication bias.
Measures of treatment effect
Dichotomous data
For dichotomous data, we presented results as summary risk ratio
with 95% confidence intervals.
Continuous data
We used the mean difference if outcomes were measured in the
same way between trials.We planned to use the standardised mean
difference to combine trials that measured the same outcome, but
used different methods.
Unit of analysis issues
Cluster-randomised trials
No cluster-randomised trials were identified by the search strategy.
In future versions of the review, if such trials are identified, we
will include cluster-randomised trials in the analyses along with
individually-randomised trials. We will adjust their sample sizes
using the methods described in the Handbook using an estimate
of the intracluster correlation co-efficient (ICC) derived from the
trial (if possible), from a similar trial or from a study of a similar
population. If we use ICCs from other sources, we will report this
and conduct sensitivity analyses to investigate the effect of varia-
tion in the ICC. If we identify both cluster-randomised trials and
individually-randomised trials, we plan to synthesise the relevant
information. We will consider it reasonable to combine the re-
sults from both if there is little heterogeneity between the study
designs and the interaction between the effect of intervention and
the choice of randomisation unit is considered to be unlikely.
We will also acknowledge heterogeneity in the randomisation unit
and perform a sensitivity analysis to investigate the effects of the
randomisation unit.
Dealing with missing data
For included studies, levels of attrition were noted. In future up-
dates, if more eligible studies are included, the impact of including
studies with high levels of missing data in the overall assessment
of treatment effect will be explored by using sensitivity analysis.
For all outcomes, analyses were carried out, as far as possible, on
an intention-to-treat basis, i.e. we attempted to include all partici-
pants randomised to each group in the analyses. The denominator
for each outcome in each trial was the number randomised minus
any participants whose outcomes were known to be missing.
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Assessment of heterogeneity
We assessed statistical heterogeneity in each meta-analysis using
the Tau², I² and Chi² statistics. We regarded heterogeneity as sub-
stantial if an I² was greater than 30% and either a Tau² was greater
than zero, or there was a low P value (less than 0.10) in the Chi²
test for heterogeneity. Had we identified substantial heterogeneity
(above 30%), we planned to explore it by pre-specified subgroup
analysis; we did not carry out this further analysis in this version
of the review due to insufficient data.
Assessment of reporting biases
In future updates, if there are 10 or more studies in the meta-
analysis, we will investigate reporting biases (such as publication
bias) using funnel plots. We will assess funnel plot asymmetry
visually. If asymmetry is suggested by a visual assessment, we will
perform exploratory analyses to investigate it.
Data synthesis
We carried out statistical analysis using the Review Manager soft-
ware (RevMan 2014).We used fixed-effect meta-analysis for com-
bining data where it was reasonable to assume that studies were
estimating the same underlying treatment effect: i.e. where trials
were examining the same intervention, and the trials’ populations
and methods were judged sufficiently similar.
If there was clinical heterogeneity sufficient to expect that the un-
derlying treatment effects differed between trials, or if substan-
tial statistical heterogeneity was detected, we used random-effects
meta-analysis to produce an overall summary, if an average treat-
ment effect across trials was considered clinically meaningful. The
random-effects summary represents the average range of possi-
ble treatment effects and we discussed the clinical implications of
treatment effects differing between trials. If the average treatment
effect was not clinically meaningful, we did not combine trials.
For results where we have used random-effects analyses, the results
have been presented as the average treatment effect with 95% con-
fidence intervals, and the estimates of Tau² and I².
Subgroup analysis and investigation of heterogeneity
Had we identified substantial heterogeneity, we planned to inves-
tigate it using subgroup analyses.
We planned the following subgroup analyses.
• Clinical estimation based on palpation of the uterus versus
ultrasound scanning.
• Maternal diabetes versus no maternal diabetes.
• Previous macrosomic infant versus no previous macrosomic
infant.
We planned to use the primary outcomes in subgroup analysis.
In this version of the review too few studies were included to allow
meaningful subgroup analyses. If sufficient data are available for
future updates we will assess subgroup differences by interaction
tests available within RevMan (RevMan 2014). We will report the
results of subgroup analyses quoting the Chi² statistic and P value,
and the interaction test I² value.
Sensitivity analysis
We planned to carry out sensitivity analyses to explore the effect of
trial quality assessed by concealment of allocation, high attrition
rates, or both, with poor-quality studies being excluded from the
analyses in order to assess whether this makes any difference to the
overall result. In this version of the review there were insufficient
data to allow for these planned analyses.
R E S U L T S
Description of studies
Results of the search
We identified 10 reports of five trials. Four trials (nine reports)
involving 1190 women, are included and one trial (Perlitz 2014)
is in the Ongoing studies section.
Included studies
Study design and settings
We included four randomised controlled trials (Boulvain 2015;
Gonen 1997; LIBBY 1998; Tey 1995).
The trial contributing most data to the review (Boulvain 2015),
was a multi-centre RCT carried out in 19 hospitals in France,
Switzerland and Belguim. Recruitment was between 2002 to 2009
and 822 women were randomised. The other three studies in-
cluded in the reviewwere carried out in Israel, USA andUKduring
the1990s had smaller sample sizes. In the study by Gonen 1997,
273 women with a gestational age of 38 completed weeks or more
were recruited. The LIBBY 1998 and Tey 1995 studies recruited
women after 37 weeks (with 59 and 40 women randomised re-
spectively).
Participants
In two trials womenwere includedwhen fetal weight, estimated by
ultrasound examination, was between 4000 g and 4500 g (Gonen
1997), or between 4000 g and 4750 g (Tey 1995). The third trial (
LIBBY 1998) includedwomenwhose fetus was estimated toweigh
more than the 97th percentile at the time of inclusion. The fourth
trial (Boulvain 2015), included women whose fetus was estimated
by sonograph toweighmore than the 95th centile.When estimated
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fetal weight was greater than 4500 g in the Gonen 1997 trial,
elective caesarean section was performed. Women with diabetes
were excluded from two of these trials (Gonen 1997; Tey 1995).
In the Boulvain 2015 trial, women with diabetes treated with
insulin were excluded, although 10% of included participants had
gestational diabetes mellitus (GDM) controlled by diet. Limited
information is available for the LIBBY 1998 pilot study.
Interventions and comparisons
In the largest trial (Boulvain 2015), labour was induced between
37+0 and 38+6 weeks and within three days or randomisation. The
method of induction was at the discretion of the attending physi-
cian and according to local protocol. Women with unfavourable
cervix had cervical ripening with misoprostol or prostaglandin E2
(PGE2) followed by oxytocin infusion if labour had not started.
In the other trials, the method used for labour induction also
depended on cervical status (prostaglandins for cervical ripening
in the case of an unfavourable cervix, otherwise oxytocin infusion).
Women in the expectantmanagement groupunderwent induction
of labour upon completion of 42 weeks of gestation in the Gonen
1997 trial.
We obtained additional (unpublished) information for the four
included studies. All the results of the Libby pilot study are un-
published (LIBBY 1998).
Excluded studies
There are no excluded studies.
Risk of bias in included studies
See Figure 1 and Figure 2 for a summary of ’Risk of bias’ assess-
ments in studies.
Figure 1. ’Risk of bias’ graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 2. ’Risk of bias’ summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
Generation of the randomisation sequence
All studies used a computer-generated table of random numbers
or Internet-based randomisation (low risk of bias).
Allocation concealment
In two of the studies, sealed, sequentially numbered, opaque en-
velopes were used (LIBBY 1998; Tey 1995) and the Boulvain 2015
trial used a central randomisation service (all three studies assessed
as low risk of bias). In the other report, the method for conceal-
ment of the random allocation was not described (Gonen 1997)
(unclear risk of bias).
Blinding
Although blinding of women and staff was not reported in three
studies (Gonen 1997; LIBBY 1998; Tey 1995) we have assumed
that it had not been attempted. It was reported to be not possible
in one study (Boulvain 2015); all four studies were assessed as high
risk of bias for performance bias. There was no mention of any
attempt to blind outcome assessors in three studies (Gonen 1997;
LIBBY 1998; Tey 1995), and again, we assumed that it had not
been attempted and assessed these studies as high risk of bias for
detection bias. In one study it was stated that the assessment of the
primary outcome was by investigators masked to group allocation
(Boulvain 2015); we assessed this study as unclear risk of bias for
this domain as most outcomes would be recorded in case notes by
staff aware of the intervention group.
Incomplete outcome data
In one study (Gonen 1997), a few women (six in the induction
group and five in the expectant group) were excluded from the
study after randomisation, either because of withdrawal of consent
or because they were lost to follow-up. Apart from the fact that
these women were excluded, an intention-to-treat analysis was
performed (low risk of bias). In the LIBBY pilot (LIBBY 1998),
29/30 women in the induction group had induction, compared to
14/29 in the expectant management group; analysis was however
performed on an intention-to-treat basis (low risk of bias). In
the Boulvain 2015 study there was very little attrition bias (822
women randomised; 818 included in the analysis, two women in
each group were lost to follow-up) (low risk of bias). In the fourth
study (Tey 1995), there was limited information in the abstract
report (unclear risk of bias).
Selective reporting
All expected outcome results were reported in one study (Gonen
1997) (low risk of bias). In the Boulvain 2015 trial, we had access
to the trial protocol and most outcomes reported in the main
trial report were pre-specified, there were some changes during the
study as more centres were recruited (unclear risk of bias). It was
not possible to tell if selective outcome reporting was apparent in
the two remaining studies (LIBBY 1998; Tey 1995) (unclear risk
of bias).
Other potential sources of bias
Baseline characteristics were similar between groups and no other
bias was apparent in one study (Gonen 1997) (low risk of bias).
It was not possible to tell if other sources of bias were apparent
in the remaining three studies (Boulvain 2015; LIBBY 1998; Tey
1995) (unclear risk of bias).
Effects of interventions
See: Summary of findings for the main comparison Induction
of labour versus expectant management for suspected fetal
macrosomia
Induction of labour versus expectant management for
suspected fetal macrosomia (four studies, 1190
women)
Primary outcomes
We identified four trials (Boulvain 2015; Gonen 1997; LIBBY
1998; Tey 1995), involving a total of 1190 women.
Maternal outcomes
Compared to expectant management, induction of labour for sus-
pected macrosomia has not been shown to reduce the risk of cae-
sarean section (risk ratio (RR) 0.91, 95% confidence interval (CI)
0.76 to 1.09; 1190women; four studies,moderate-quality evidence)
Analysis 1.1, orinstrumental delivery (RR 0.86, 95% CI 0.65 to
1.13; 1190 women; four studies, low-quality evidence), Analysis
1.2.
Perinatal outcomes
The risks of shoulder dystocia and fracture (any) were lower
in the induction group (RR 0.60, 95% CI 0.37 to 0.98; 1190
women; four trials, moderate-quality evidence; and RR 0.20, 95%
CI 0.05 to 0.79; 1190 women; four studies, high-quality evidence,
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respectively) Analysis 1.3; Analysis 1.5. However, there were no
clear differences between groups for brachial plexus injury, al-
though this outcome was infrequent with one trial reporting two
cases of brachial plexus injury in the expectant management group
(Gonen 1997) (RR 0.21, 95% CI 0.01 to 4.28; four studies, 1190
women, low-quality evidence) (Analysis 1.4). There was no strong
evidence of any difference between groups for measures of neona-
tal asphyxia: low infant Apgar scores (less than seven) or low
arterial cord blood pH (RR 1.51, 95% CI 0.25 to 9.02; 858 in-
fants; two trials, low-quality evidence; and, RR 1.01, 95% CI 0.46
to 2.22; 818 infants; one trial, moderate-quality evidence, respec-
tively), Analysis 1.6; Analysis 1.7.
Secondary outcomes
Maternal outcomes
All four studies reported spontaneous delivery and there was no
clear evidence of differences between groups (RR 1.09, 95% CI
0.99 to 1.20; 1190 women) (Analysis 1.8). Two studies reported
third- and fourth-degree perineal tears, but only one had es-
timable data (Boulvain 2015); in this study the number of women
with tears was increased in the induction of labour group, although
the 95% CI was wide for this outcome (RR 3.70, 95% CI 1.04 to
13.17; 858 women), Analysis 1.9.
No information is available aboutmaternal dissatisfaction (pain,
sexual dysfunction).
Infant outcomes
Three of the studies reported perinatal mortality, but there were
no events reported in either group.
When cranial sonography was performed, a similar proportion of
newborns with intraventricular haemorrhage was observed be-
tween the intervention and the control groups (RR 1.06, 95% CI
0.19 to 5.96; 933 infants; three studies), Analysis 1.11. One study
reported on the outcome infant convulsions but there were no
events in either group Analysis 1.12. There were no clear differ-
ences between groups for admission to neonatal intensive care in
two studies reporting this outcome (RR 0.66, 95% CI 0.35 to
1.24; 858 infants; two studies) Analysis 1.13.
In the pooled analysis, mean infant birthweight was lower in
the induction group, although there were high levels of statistical
heterogeneity for this outcome (mean difference (MD) -178.03 g,
95% CI -315.26 to -40.81; 1190 infants; four studies; I2 = 89%)
Analysis 1.14.). For one study (LIBBY 1998), data for this out-
come were reported as median and interquartile range; in order
to use these data in the meta-analysis, we entered the median as
the measure of central tendency and estimated the standard devi-
ations from the interquartile range. As we had estimated the stan-
dard deviations (and assumed that they were the same in both the
intervention and control groups), we also carried out a sensitiv-
ity analysis using the standard deviations reported in the largest
trial (Boulvain 2015); the sensitivity analysis showed similar re-
sults (MD -169.81, 95% CI -321.36 to -18.25) Analysis 1.15.
It must be noted that in two of the trials (Gonen 1997; Tey 1995),
despite induction of labour in the intervention group, groups were
similar with regard to mean birthweight. The contrast between
groups was larger in the LIBBY 1998 (-295 g median difference
between groups) and Boulvain 2015 trials (-287 g difference).
There was no information on long-term disability in childhood
in any of the studies.
Non pre-specified outcomes
The trial contributing most data (Boulvain 2015) reported out-
comes that were not pre-specified in the protocol for this review.
First, clinically significant shoulder dystocia, had been pre-spec-
ified as a secondary outcome in the trial, and defined as “diffi-
culty with delivery of the shoulders that was not resolved by the
McRoberts’ manoeuvre (flexion of the maternal thighs), usually
combined with suprapubic pressure”. It was reduced in the induc-
tion of labour group (RR 0.32, 95% CI 0.12 to 0.85; infants =
818; one study) (Analysis 1.16). The authors of the trial had also
pre-specified their primary fetal trial outcome as a composite of
significant should dystocia and a range of birth injuries and death.
That composite outcome was also reduced (RR 0·32 95%CI 0·15
to 0·71; infants = 818) (Analysis 1.17).
A further outcome reported by Boulvain 2015, was the use of
neonatal phototherapy. Although this had been pre-specified nei-
ther in the trial nor in this review, it was increased in the induc-
tion of labour group; induction 45 (11%) versus control 27 (7%),
nominal P = 0·03 (RR 1.68, 95% CI 1.07 to 2.66; infants = 818)
)(Analysis 1.18).
Finally, Gonen 1997 reported cephalohematoma, and there was
no clear evidence that this outcome differed between groups (RR
2.07, 95% CI 0.53 to 8.13; infants = 273) (Analysis 1.19.
Insufficient data were available to allow us to perform planned
subgroup analysis.
D I S C U S S I O N
Summary of main results
The review included four randomised controlled trials involving
1190women, although one trial (Boulvain 2015)with 822women
contributed most of the data.
Induction of labour shortly before term for suspected fetal macro-
somia in non-diabetic women reduces both neonatal fractures and
shoulder dystocia. The number needed to treat per fracture pre-
vented is 60. Specifically, the evidence does not seem to suggest
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that a policy of induction increases the risk of caesarean section or
instrumental birth, and may slightly reduce the former. Neonatal
brachial plexus injury was reported for two babies in the control
group, but the power of the included studies to show a differ-
ence between groups for such a rare event is limited. In one trial
(Boulvain 2015), an increase in phototherapy in the induction
group, was observed, but this was not pre-specified in that trial
nor in this review, and none of the infants involved had bilirubin
levels over the normal cut-off for phototherapy in the trial centres,
namely 350 mmol/L, and the nominal statistical test result took
no account of multiple testing. We are therefore uncertain of the
clinical significance of this finding. All other neonatal outcomes
were similar between groups. One trial (Boulvain 2015), also pre-
specified a composite primary fetal trial outcome of significant
shoulder dystocia and other types of birth injury. Although not
pre-specified in our review protocol, it was significantly reduced
in the induction group in that trial. Finally, there was an unan-
ticipated increase in third- and fourth-degree perineal tears in the
induction group in the same trial.
Overall completeness and applicability of
evidence
The meta-analysis of the effect of induction on mean birthweight
showed a high level of heterogeneity, which was explained by dif-
ferences in trial design. Two studies (Gonen 1997; Tey 1995) in-
cludedpregnancies around40weekswith an estimated fetal weight
of more than 4000 g. As a result, despite induction of labour,
the groups were similar with regard to gestational age at delivery
and mean birthweight. The intervention was probably not per-
formed early enough to avoid excessive birthweight. The two trials
(Boulvain 2015; LIBBY 1998) that included women at an earlier
gestational age observed a larger contrast in birthweight between
groups.
Quality of the evidence
The overall quality of the evidence of the three smaller trials was
at best moderate. However, the new trial (Boulvain 2015), apart
from lack of blinding was assessed as being at low risk of bias
and as this trial now dominates the review, we have judged that
overall findings were at fairly low risk of bias. This is summarised
in the ’Risk of bias’ summary figures, Figure 1; Figure 2. We used
GRADEpro software to grade evidence for our primary outcomes;
for fracture the evidence was rated as high quality while for other
primary outcomes, evidence was downgraded to moderate or low
quality due to risk of bias relating to lack of blinding or imprecision
of effect estimates.
Potential biases in the review process
We are aware that there is the potential to introduce bias at every
stage in the review process and we took steps to minimise bias.
At least two review authors independently assessed each study for
possible inclusion, and carried out data extraction and assessment
of study quality for included studies. Assessing risk of bias is a
matter of judgment rather than an exact science and it is possible
that a different review team may have made different decisions.
Two review team authors (Boulvain and Irion) are authors of the
recently included trial (Boulvain 2015), and a third (Thornton) is
an author of another included trial (LIBBY 1998). They were not
involved in carrying out data extraction or assessing risk of bias
for the trials which they had authored.
Agreements and disagreements with other
studies or reviews
The results of this review disagree with another non-Cochrane sys-
tematic review which examined induction of labour versus expec-
tantmanagement for suspected fetal macrosomia (Sanchez-Ramos
2002). That review included both randomised controlled trials
and observational studies. The authors found no difference in
rates of caesarean section, operative vaginal delivery or shoulder
dystocia between induction of labour and expectant management
groups for the two trials (313 women) included in their system-
atic review. Both trials included in the Sanchez-Ramos 2002 sys-
tematic review are also included in this review (Gonen 1997; Tey
1995). However, the observational data included in the review
(Sanchez-Ramos 2002) suggested an increased caesarean delivery
rate without improving perinatal outcomes for labour induction.
The finding that a policy of near term induction for suspected
macrosomia does not increase caesarean section rates will be coun-
terintuitive for many obstetricians and midwives who have long
believed, from non-randomised studies, that induction increases
the rate of caesareandelivery.However, it is in agreementwith three
recent non-Cochrane reviews (Mishanina 2014; Saccone 2015;
Wood 2014), which measured the effect of induction for a range
of indications on caesarean. All three reviews restricted their anal-
yses to randomised controlled trials. The two which included the
largest number of trials (Mishanina 2014; Wood 2014), 157 and
37 trials respectively, reported that induction significantly reduced
caesarean rates and the other review (Saccone 2015), which that
included only six trials reported no significant effect. This external
evidence gives us confidence in our conclusion that the policy of
induction for suspected macrosomia does not increase caesareans
rates. Since our observed point estimate for the effect on caesarean
of a risk ratio (RR) of 0.91 is close to the RR of 0.88 taken from
the largest systematic review (Mishanina 2014), our best estimate
is that a policy of induction may slightly reduce the number of
caesarean births.
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A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There is now evidence that a systematic policy of labour induction
for suspected fetal macrosomia in non-diabetic women reduces
mean birthweight and birth fractures. Although the trials are too
small to show a meaningful reduction in brachial plexus injury,
we did not observe any adverse effect in terms of an increased rate
of caesarean section or instrumental birth.
The evidence justifies a policy of telling women about these ad-
vantages, and the lack of any clear evidence that induction affects
the way the baby is born. At the same time, there may be disad-
vantages of induction, and findings from this review suggest third-
and fourth-degree perineal tears may be increased in the induction
group.
The exact gestation at which doctors and parents will decide on
induction cannot be specified from these data. Induction between
38 + 0 and 38 + 6 weeks, i.e. at the later gestation considered,
is likely to minimise the risks of iatrogenic prematurity but may
not achieve much benefit in terms of birthweight and birth injury
reduction. Induction at 37 weeks may have the opposite trade-off
of risks and benefits.
Implications for research
Although some parents and doctors may feel the evidence already
justifies induction, others may justifiably disagree. Further trials
of induction shortly before term for suspected fetal macrosomia
remain justified. Such trials should concentrate on refining the
optimum gestation of induction, and improving the accuracy of
the diagnosis of macrosomia.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Boulvain 2015
Methods Multi-centre randomised controlled trial in collaboration with 19 teaching hospitals,
members of GROG group, in France, Switzerland and Belguim. Recruitment 2002-
2009
Participants 822 women randomised. Women with singleton fetus with cephalic presentation and
no contraindications to vaginal delivery. Women were screened between 36-38 weeks’
gestation and those with a fetus with an estimated weight above the 95th percentile at
37 to 38 weeks of gestation, confirmed clinically and then by sonography were included
Exclusion criteria: any contraindication to induction of labour or vaginal delivery or
a history of caesarean section, neonatal trauma or shoulder dystocia, severe urinary or
faecal incontinence, or insulin treated diabetes.
Interventions Intervention: 409 women allocated to induction of labour. Labour was induced between
37+0 and 38+6 weeks and within 3 days or randomisation. The method of induction
was at the discretion of the attending physician and according to local protocol. Women
with unfavourable cervix had cervical ripening with misoprostol or PGE2 followed by
oxytocin infusion if labour had not started
Comparison group: 413 women allocated to expectant management. Women wereman-
aged expectantly until labour started spontaneously or the woman required induction
(depending on local policy), for example, if PROMoccurred or the pregnancy continued
beyond 41 weeks
Outcomes The primary outcome was a composite outcome: significant shoulder dystocia, fracture
of the clavicle or long bone, brachial plexus injury, intracranial haemorrhage or death
Significant shoulder dystocia was defined as difficulty with delivering the shoulders that
was not resolved by the McRoberts’ manoeuvre (flexion of the maternal thighs usually
combined with suprapubic pressure) or requiring other manoeuvres (Woods, Rubin or
Jaquemier) to rotate the fetus to displace the fetal shoulder impacted behind thematernal
pubic bone. The definition also included a delay of 60s or more between delivery of the
head and the body
Secondary outcomes: mode of delivery, PPH (1000 mL or more), maternal blood trans-
fusion, and anal sphincter tear, cord blood pH < 7.10, Apgar score < 7 at 5 minutes,
admission to NICU, hyperbilirubinaemia (max value > 350 mmol/L)
Notes 2 of the authors of this review (MB and OI) were investigators on this trial; these author
were not involved in data extraction or in assessing risk of bias for this study. Independent
data extraction was carried out by other members of the review team
Risk of bias
Bias Authors’ judgement Support for judgement
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Boulvain 2015 (Continued)
Random sequence generation (selection
bias)
Low risk Randomisation by centralised computer
with permuted blocks (block size 4-8) with
stratification by centre
Allocation concealment (selection bias) Low risk Central randomisation. Clinicians and par-
ticipants had no access to the randomi-
sation and women were randomised after
consent had been obtained
Blinding of participants and personnel
(performance bias)
All outcomes
High risk It was not feasible to blind women or clin-
ical staff to treatment allocation and lack
of blinding may have affected clinical man-
agement and outcomes
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk It was stated that the assessment of the pri-
mary outcome was by investigators masked
to group allocation
Incomplete outcome data (attrition bias)
All outcomes
Low risk There was very little attrition bias (822
women randomised 818 included in the
analysis, 2 women in each group were lost
to follow-up)
Selective reporting (reporting bias) Unclear risk The trial recruited between2002 and2009.
It was first registered in 2005 which was
at the point recruitment expanded from 1
to 2 countries and from 4 to 19 hospi-
tals, so fairly early in the overall recruit-
ment numbers. There is also a trial proto-
col available in French. Both registry and
protocol planned sample size was 1000. In-
stead recruitment ended due to financial
constraints in Jan 2009 before any analyses
were conducted
The published primary outcome “a com-
posite of significant shoulder dystocia, frac-
ture of the clavicle or a long bone, brachial
plexus injury, intracranial haemorrhage, or
death” includes two components “signifi-
cant shoulder dystocia” and a delay of > 60
seconds between delivery of the head and
body, was notmentioned in the registry but
was set out in the protocol
For secondary outcomes, reduction of ma-
ternal morbidity and caesarean were men-
tioned in the registry and other secondary
outcomes were pre-specified in the proto-
col. The fetal secondary outcomes, CPAP,
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Boulvain 2015 (Continued)
phototherapy and hypoglycaemia and the
maternal secondaries, sepsis, fever (> 38.5
C) and retained placentawere not pre-spec-
ified in either the registry or the protocol
Other bias Unclear risk Baseline characteristics were similar be-
tween groups (although maternal weight
gain appeared greater in the expectantman-
agement group (15.6 kg versus 14.7 kg)
Gonen 1997
Methods Randomised controlled trial carried out in Israel.
Participants 273 women with clinical or previous ultrasound suspicion of macrosomia, or with past
history of macrosomia, underwent an ultrasound examination. Women were eligible if
ultrasound estimated fetal weight, performed at 38 completed weeks or more, was be-
tween 4000 g and 4500 g. Women with diabetes, non-cephalic presentation, previous
caesarean section, or indication for labour induction other than macrosomia were ex-
cluded. 6 women in the induction of labour group and 3 in the expectant management
group refused to participate after randomisation. 2 women in the expectant management
group were lost to follow-up
Interventions Immediate induction of labour using either oxytocin or prostaglandins according to
cervical status. Women in the expectant management group: labour was induced at 42
completed weeks of gestation unless fetal distress was suspected
Outcomes Caesarean section, instrumental delivery, and spontaneous delivery.
Mean birthweight, mean arterial cord blood pH, shoulder dystocia, cephalohematoma,
clavicular fracture, brachial plexus palsy, intraventricular haemorrhage.
Some results are given stratified according to parity.
Notes Additional information kindly provided by the authors.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Table of random numbers generated by
computer.
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk It was not feasible to blind women or clin-
ical staff to treatment allocation and lack
of blinding may have affected clinical man-
agement and outcomes
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Gonen 1997 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not reported, likely that outcome assess-
ment was not blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk All losses accounted for: 6 refused to par-
ticipate in induction group and 3 in expec-
tant group; 2 lost to follow-up from expec-
tant group; this left 273 women available
for analysis: 134 in induction group and
139 in the expectant group
Selective reporting (reporting bias) Low risk All expected outcome results reported.
Other bias Low risk Baseline characteristics similar between
groups. No other bias apparent
LIBBY 1998
Methods Randomised controlled trial carried out in two centres in the UK
Participants 59 women (30 induction; 29 await spontaneous labour) with a fetus estimated above the
97th percentile (abdominal circumference, estimated fetal weight according to Chitty
1994).
Interventions Immediate induction of labour using either oxytocin or prostaglandins. Women in the
expectant management group: labour was induced at 42 completed weeks of gestation
Outcomes Mode of delivery, birthweight, delay and adverse maternal or neonatal outcome
Notes No adverse fetal or maternal outcome. Standard deviation estimated from the informa-
tion available (interquartile ranges)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Table of random numbers generated by
computer.
Allocation concealment (selection bias) Low risk Sealed opaque, consecutively-numbered
envelopes.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk It was not feasible to blind women or clin-
ical staff to treatment allocation and lack
of blinding may have affected clinical man-
agement and outcomes
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LIBBY 1998 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not reported; it is likely that outcome as-
sessment was not blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk 29/30 women in the induction group had
induction, compared to 14/29 in the expec-
tant management group; analysis was how-
ever performed on an intention-to-treat ba-
sis
Selective reporting (reporting bias) Unclear risk Not possible to tell - unpublished data.
Other bias Unclear risk Unclear.
Tey 1995
Methods Randomised controlled trial carried out in the USA.
Participants 40 women at 37 to 42 weeks, with an ultrasound estimated fetal weight between 4000
g and 4750 g
Interventions Induction of labour was performed with PGE2 gel if the cervical status was unfavourable
(Bishop score < 6), followed by oxytocin infusion
Outcomes Mean birthweight, caesarean section and shoulder dystocia.
Notes Additional information kindly provided by the authors.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated table of random
numbers.
Allocation concealment (selection bias) Low risk Sealed opaque, consecutively-numbered
envelopes, prepared by an individual not
involved in the study. Envelopes were
opened only after inclusion of women
Blinding of participants and personnel
(performance bias)
All outcomes
High risk It was not feasible to blind women or clin-
ical staff to treatment allocation and lack
of blinding may have affected clinical man-
agement and outcomes
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not reported; it was likely that outcome
assessment was not blinded
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Tey 1995 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not clear - only published as an abstract.
Selective reporting (reporting bias) Unclear risk Not clear - only published as an abstract.
Other bias Unclear risk Not clear - only published as an abstract.
CPAP: continuous positive airways pressure
NICU: neonatal intensive care unit
PGE2: prostaglandins E2
PPH: postpartum haemorrhage
PROM: premature rupture of membranes
Characteristics of ongoing studies [ordered by study ID]
Perlitz 2014
Trial name or title Induction of labour versus expectant management of large for gestational age/macrosomic babies at term. A
multi-center trial (IOLEMMT)
Methods Randomised controlled trial.
Participants Women 18-45 years age with large for gestational age or suspected macrosomic babies 38 to 40 + 3 weeks’
gestation with singleton pregnancy, cephalic presentation with estimated fetal weight 3800 to 4500 g.Women
with diabetes, major fetal malformation or previous caesarean birth excluded. Proposed sample: 474 women
Interventions Induction of labour versus expectant management (up to 40 weeks + 6 days)
Outcomes Shoulder dystocia, brachial plexus injuries, fracture, intraventricular haemorrhage, cephalhematoma, cae-
sarean section
Starting date January 2015.
Contact information Dr Yuri Perlitz yperlitz@poria.health.gov.II
Notes Estimated completion 2019.
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D A T A A N D A N A L Y S E S
Comparison 1. Induction versus expectant management
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Caesarean section 4 1190 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.76, 1.09]
2 Instrumental delivery 4 1190 Risk Ratio (M-H, Fixed, 95% CI) 0.86 [0.65, 1.13]
3 Shoulder dystocia 4 1190 Risk Ratio (M-H, Fixed, 95% CI) 0.60 [0.37, 0.98]
4 Brachial plexus injury 4 1190 Risk Ratio (M-H, Fixed, 95% CI) 0.21 [0.01, 4.28]
5 Fracture (any) 4 1190 Risk Ratio (M-H, Fixed, 95% CI) 0.20 [0.05, 0.79]
6 Low Apgar score (5 minutes) 2 858 Risk Ratio (M-H, Fixed, 95% CI) 1.51 [0.25, 9.02]
7 Low arterial cord blood pH (<
7.10)
1 818 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.46, 2.22]
8 Spontaneous delivery 4 1190 Risk Ratio (M-H, Fixed, 95% CI) 1.09 [0.99, 1.20]
9 Third- and fourth-degree
perineal tears
2 858 Risk Ratio (M-H, Fixed, 95% CI) 3.70 [1.04, 13.17]
10 Perinatal mortality 3 917 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
11 Intracranial haemorrhage 3 933 Risk Ratio (M-H, Fixed, 95% CI) 1.06 [0.19, 5.96]
12 Convulsions 1 40 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
13 Admission to neonatal intensive
care unit
2 858 Risk Ratio (M-H, Fixed, 95% CI) 0.66 [0.35, 1.24]
14 Mean birthweight (g) 4 1190 Mean Difference (IV, Random, 95% CI) -178.03 [-315.26, -
40.81]
15 Sensitivity analysis: Mean
birthweight (g)
4 1190 Mean Difference (IV, Random, 95% CI) -169.81 [-321.36, -
18.25]
16 Non pre-specified outcome:
significant shoulder dystocia
1 818 Risk Ratio (M-H, Fixed, 95% CI) 0.32 [0.12, 0.85]
17 Non pre-specified outcome:
serious neonatal morbidity or
death (composite outcome)
1 818 Risk Ratio (M-H, Fixed, 95% CI) 0.32 [0.15, 0.71]
18 Non pre-specified outcome: use
of phototherapy
1 818 Risk Ratio (M-H, Fixed, 95% CI) 1.68 [1.07, 2.66]
19 Non pre-specified outcome:
cephalohematoma
1 273 Risk Ratio (M-H, Fixed, 95% CI) 2.07 [0.53, 8.13]
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Analysis 1.1. Comparison 1 Induction versus expectant management, Outcome 1 Caesarean section.
Review: Induction of labour at or near term for suspected fetal macrosomia
Comparison: 1 Induction versus expectant management
Outcome: 1 Caesarean section
Study or subgroup Induction
Expectant
manage-
ment Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Boulvain 2015 114/407 130/411 74.1 % 0.89 [ 0.72, 1.09 ]
Gonen 1997 26/134 30/139 16.9 % 0.90 [ 0.56, 1.44 ]
LIBBY 1998 11/30 8/29 4.7 % 1.33 [ 0.63, 2.83 ]
Tey 1995 6/19 8/21 4.4 % 0.83 [ 0.35, 1.95 ]
Total (95% CI) 590 600 100.0 % 0.91 [ 0.76, 1.09 ]
Total events: 157 (Induction), 176 (Expectant management)
Heterogeneity: Chi2 = 1.08, df = 3 (P = 0.78); I2 =0.0%
Test for overall effect: Z = 1.06 (P = 0.29)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours induction Favours expectant
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Analysis 1.2. Comparison 1 Induction versus expectant management, Outcome 2 Instrumental delivery.
Review: Induction of labour at or near term for suspected fetal macrosomia
Comparison: 1 Induction versus expectant management
Outcome: 2 Instrumental delivery
Study or subgroup Induction Expectant Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Boulvain 2015 54/407 68/411 74.8 % 0.80 [ 0.58, 1.12 ]
Gonen 1997 17/134 18/139 19.5 % 0.98 [ 0.53, 1.82 ]
LIBBY 1998 6/30 5/29 5.6 % 1.16 [ 0.40, 3.39 ]
Tey 1995 0/19 0/21 Not estimable
Total (95% CI) 590 600 100.0 % 0.86 [ 0.65, 1.13 ]
Total events: 77 (Induction), 91 (Expectant)
Heterogeneity: Chi2 = 0.64, df = 2 (P = 0.73); I2 =0.0%
Test for overall effect: Z = 1.08 (P = 0.28)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours induction Favours expectant
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Analysis 1.3. Comparison 1 Induction versus expectant management, Outcome 3 Shoulder dystocia.
Review: Induction of labour at or near term for suspected fetal macrosomia
Comparison: 1 Induction versus expectant management
Outcome: 3 Shoulder dystocia
Study or subgroup Induction Expectant Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Boulvain 2015 (1) 15/407 32/411 78.5 % 0.47 [ 0.26, 0.86 ]
Gonen 1997 5/134 6/139 14.5 % 0.86 [ 0.27, 2.77 ]
LIBBY 1998 0/30 0/29 Not estimable
Tey 1995 4/19 3/21 7.0 % 1.47 [ 0.38, 5.75 ]
Total (95% CI) 590 600 100.0 % 0.60 [ 0.37, 0.98 ]
Total events: 24 (Induction), 41 (Expectant)
Heterogeneity: Chi2 = 2.65, df = 2 (P = 0.27); I2 =25%
Test for overall effect: Z = 2.05 (P = 0.040)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours induction Favours expectant
(1) Any shoulder dystocia
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Analysis 1.4. Comparison 1 Induction versus expectant management, Outcome 4 Brachial plexus injury.
Review: Induction of labour at or near term for suspected fetal macrosomia
Comparison: 1 Induction versus expectant management
Outcome: 4 Brachial plexus injury
Study or subgroup Induction
Expectant
manage-
ment Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Boulvain 2015 0/407 0/411 Not estimable
Gonen 1997 0/134 2/139 100.0 % 0.21 [ 0.01, 4.28 ]
LIBBY 1998 0/30 0/29 Not estimable
Tey 1995 0/19 0/21 Not estimable
Total (95% CI) 590 600 100.0 % 0.21 [ 0.01, 4.28 ]
Total events: 0 (Induction), 2 (Expectant management)
Heterogeneity: not applicable
Test for overall effect: Z = 1.02 (P = 0.31)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours induction Favours expectant
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Analysis 1.5. Comparison 1 Induction versus expectant management, Outcome 5 Fracture (any).
Review: Induction of labour at or near term for suspected fetal macrosomia
Comparison: 1 Induction versus expectant management
Outcome: 5 Fracture (any)
Study or subgroup Induction
Expectant
manage-
ment Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Boulvain 2015 2/407 8/411 64.3 % 0.25 [ 0.05, 1.18 ]
Gonen 1997 0/134 4/139 35.7 % 0.12 [ 0.01, 2.12 ]
LIBBY 1998 0/30 0/29 Not estimable
Tey 1995 0/19 0/21 Not estimable
Total (95% CI) 590 600 100.0 % 0.20 [ 0.05, 0.79 ]
Total events: 2 (Induction), 12 (Expectant management)
Heterogeneity: Chi2 = 0.22, df = 1 (P = 0.64); I2 =0.0%
Test for overall effect: Z = 2.30 (P = 0.021)
Test for subgroup differences: Not applicable
0.001 0.01 0.1 1 10 100 1000
Favours induction Favours expectant
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Analysis 1.6. Comparison 1 Induction versus expectant management, Outcome 6 Low Apgar score (5
minutes).
Review: Induction of labour at or near term for suspected fetal macrosomia
Comparison: 1 Induction versus expectant management
Outcome: 6 Low Apgar score (5 minutes)
Study or subgroup Induction
Expectant
Manage-
ment Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Boulvain 2015 3/407 2/411 100.0 % 1.51 [ 0.25, 9.02 ]
Tey 1995 0/19 0/21 Not estimable
Total (95% CI) 426 432 100.0 % 1.51 [ 0.25, 9.02 ]
Total events: 3 (Induction), 2 (Expectant Management)
Heterogeneity: not applicable
Test for overall effect: Z = 0.46 (P = 0.65)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours induction Favours expectant
Analysis 1.7. Comparison 1 Induction versus expectant management, Outcome 7 Low arterial cord blood
pH (< 7.10).
Review: Induction of labour at or near term for suspected fetal macrosomia
Comparison: 1 Induction versus expectant management
Outcome: 7 Low arterial cord blood pH (< 7.10)
Study or subgroup Induction Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Boulvain 2015 12/407 12/411 100.0 % 1.01 [ 0.46, 2.22 ]
Total (95% CI) 407 411 100.0 % 1.01 [ 0.46, 2.22 ]
Total events: 12 (Induction), 12 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.02 (P = 0.98)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
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Analysis 1.8. Comparison 1 Induction versus expectant management, Outcome 8 Spontaneous delivery.
Review: Induction of labour at or near term for suspected fetal macrosomia
Comparison: 1 Induction versus expectant management
Outcome: 8 Spontaneous delivery
Study or subgroup Induction Expectant Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Boulvain 2015 239/407 212/411 64.1 % 1.14 [ 1.01, 1.29 ]
Gonen 1997 91/134 91/139 27.2 % 1.04 [ 0.88, 1.23 ]
LIBBY 1998 13/30 16/29 4.9 % 0.79 [ 0.46, 1.33 ]
Tey 1995 13/19 13/21 3.8 % 1.11 [ 0.70, 1.74 ]
Total (95% CI) 590 600 100.0 % 1.09 [ 0.99, 1.20 ]
Total events: 356 (Induction), 332 (Expectant)
Heterogeneity: Chi2 = 2.31, df = 3 (P = 0.51); I2 =0.0%
Test for overall effect: Z = 1.79 (P = 0.074)
Test for subgroup differences: Not applicable
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Analysis 1.9. Comparison 1 Induction versus expectant management, Outcome 9 Third- and fourth-degree
perineal tears.
Review: Induction of labour at or near term for suspected fetal macrosomia
Comparison: 1 Induction versus expectant management
Outcome: 9 Third- and fourth-degree perineal tears
Study or subgroup Induction Expectant Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Boulvain 2015 11/407 3/411 100.0 % 3.70 [ 1.04, 13.17 ]
Tey 1995 0/19 0/21 Not estimable
Total (95% CI) 426 432 100.0 % 3.70 [ 1.04, 13.17 ]
Total events: 11 (Induction), 3 (Expectant)
Heterogeneity: not applicable
Test for overall effect: Z = 2.02 (P = 0.043)
Test for subgroup differences: Not applicable
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Analysis 1.10. Comparison 1 Induction versus expectant management, Outcome 10 Perinatal mortality.
Review: Induction of labour at or near term for suspected fetal macrosomia
Comparison: 1 Induction versus expectant management
Outcome: 10 Perinatal mortality
Study or subgroup Induction
Expectant
manage-
ment Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Boulvain 2015 0/407 0/411 Not estimable
LIBBY 1998 0/30 0/29 Not estimable
Tey 1995 0/19 0/21 Not estimable
Total (95% CI) 456 461 Not estimable
Total events: 0 (Induction), 0 (Expectant management)
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Not applicable
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Analysis 1.11. Comparison 1 Induction versus expectant management, Outcome 11 Intracranial
haemorrhage.
Review: Induction of labour at or near term for suspected fetal macrosomia
Comparison: 1 Induction versus expectant management
Outcome: 11 Intracranial haemorrhage
Study or subgroup Induction Expectant Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Boulvain 2015 0/407 0/411 Not estimable
Gonen 1997 3/44 2/31 100.0 % 1.06 [ 0.19, 5.96 ]
Tey 1995 0/19 0/21 Not estimable
Total (95% CI) 470 463 100.0 % 1.06 [ 0.19, 5.96 ]
Total events: 3 (Induction), 2 (Expectant)
Heterogeneity: not applicable
Test for overall effect: Z = 0.06 (P = 0.95)
Test for subgroup differences: Not applicable
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Analysis 1.12. Comparison 1 Induction versus expectant management, Outcome 12 Convulsions.
Review: Induction of labour at or near term for suspected fetal macrosomia
Comparison: 1 Induction versus expectant management
Outcome: 12 Convulsions
Study or subgroup Induction
Expectant
manage-
ment Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Tey 1995 0/19 0/21 Not estimable
Total (95% CI) 19 21 Not estimable
Total events: 0 (Induction), 0 (Expectant management)
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Not applicable
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Analysis 1.13. Comparison 1 Induction versus expectant management, Outcome 13 Admission to neonatal
intensive care unit.
Review: Induction of labour at or near term for suspected fetal macrosomia
Comparison: 1 Induction versus expectant management
Outcome: 13 Admission to neonatal intensive care unit
Study or subgroup Induction
Expectant
manage-
ment Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Boulvain 2015 15/407 23/411 100.0 % 0.66 [ 0.35, 1.24 ]
Tey 1995 0/19 0/21 Not estimable
Total (95% CI) 426 432 100.0 % 0.66 [ 0.35, 1.24 ]
Total events: 15 (Induction), 23 (Expectant management)
Heterogeneity: not applicable
Test for overall effect: Z = 1.29 (P = 0.20)
Test for subgroup differences: Not applicable
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Analysis 1.14. Comparison 1 Induction versus expectant management, Outcome 14 Mean birthweight (g).
Review: Induction of labour at or near term for suspected fetal macrosomia
Comparison: 1 Induction versus expectant management
Outcome: 14 Mean birthweight (g)
Study or subgroup Induction Expectant
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Boulvain 2015 407 3831 (324) 411 4118 (392) 28.9 % -287.00 [ -336.27, -237.73 ]
Gonen 1997 134 4062.8 (306.9) 139 4132.8 (347.4) 27.4 % -70.00 [ -147.69, 7.69 ]
LIBBY 1998 30 3705 (148.15) 29 4000 (251.85) 25.5 % -295.00 [ -400.89, -189.11 ]
Tey 1995 19 4250 (317) 21 4253 (338) 18.1 % -3.00 [ -206.02, 200.02 ]
Total (95% CI) 590 600 100.0 % -178.03 [ -315.26, -40.81 ]
Heterogeneity: Tau2 = 16305.42; Chi2 = 27.64, df = 3 (P<0.00001); I2 =89%
Test for overall effect: Z = 2.54 (P = 0.011)
Test for subgroup differences: Not applicable
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Analysis 1.15. Comparison 1 Induction versus expectant management, Outcome 15 Sensitivity analysis:
Mean birthweight (g).
Review: Induction of labour at or near term for suspected fetal macrosomia
Comparison: 1 Induction versus expectant management
Outcome: 15 Sensitivity analysis: Mean birthweight (g)
Study or subgroup Induction Expectant
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Boulvain 2015 407 3831 (324) 411 4118 (392) 30.1 % -287.00 [ -336.27, -237.73 ]
Gonen 1997 134 4062.8 (306.9) 139 4132.8 (347.4) 28.7 % -70.00 [ -147.69, 7.69 ]
LIBBY 1998 30 3705 (324) 29 4000 (392) 21.3 % -295.00 [ -478.84, -111.16 ]
Tey 1995 19 4250 (317) 21 4253 (338) 19.9 % -3.00 [ -206.02, 200.02 ]
Total (95% CI) 590 600 100.0 % -169.81 [ -321.36, -18.25 ]
Heterogeneity: Tau2 = 19261.29; Chi2 = 26.45, df = 3 (P<0.00001); I2 =89%
Test for overall effect: Z = 2.20 (P = 0.028)
Test for subgroup differences: Not applicable
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Analysis 1.16. Comparison 1 Induction versus expectant management, Outcome 16 Non pre-specified
outcome: significant shoulder dystocia.
Review: Induction of labour at or near term for suspected fetal macrosomia
Comparison: 1 Induction versus expectant management
Outcome: 16 Non pre-specified outcome: significant shoulder dystocia
Study or subgroup Induction Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Boulvain 2015 5/407 16/411 100.0 % 0.32 [ 0.12, 0.85 ]
Total (95% CI) 407 411 100.0 % 0.32 [ 0.12, 0.85 ]
Total events: 5 (Induction), 16 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.27 (P = 0.023)
Test for subgroup differences: Not applicable
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Analysis 1.17. Comparison 1 Induction versus expectant management, Outcome 17 Non pre-specified
outcome: serious neonatal morbidity or death (composite outcome).
Review: Induction of labour at or near term for suspected fetal macrosomia
Comparison: 1 Induction versus expectant management
Outcome: 17 Non pre-specified outcome: serious neonatal morbidity or death (composite outcome)
Study or subgroup Induction Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Boulvain 2015 8/407 25/411 100.0 % 0.32 [ 0.15, 0.71 ]
Total (95% CI) 407 411 100.0 % 0.32 [ 0.15, 0.71 ]
Total events: 8 (Induction), 25 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.82 (P = 0.0048)
Test for subgroup differences: Not applicable
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Analysis 1.18. Comparison 1 Induction versus expectant management, Outcome 18 Non pre-specified
outcome: use of phototherapy.
Review: Induction of labour at or near term for suspected fetal macrosomia
Comparison: 1 Induction versus expectant management
Outcome: 18 Non pre-specified outcome: use of phototherapy
Study or subgroup Induction Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Boulvain 2015 45/407 27/411 100.0 % 1.68 [ 1.07, 2.66 ]
Total (95% CI) 407 411 100.0 % 1.68 [ 1.07, 2.66 ]
Total events: 45 (Induction), 27 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.23 (P = 0.026)
Test for subgroup differences: Not applicable
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Analysis 1.19. Comparison 1 Induction versus expectant management, Outcome 19 Non pre-specified
outcome: cephalohematoma.
Review: Induction of labour at or near term for suspected fetal macrosomia
Comparison: 1 Induction versus expectant management
Outcome: 19 Non pre-specified outcome: cephalohematoma
Study or subgroup Induction Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gonen 1997 6/134 3/139 100.0 % 2.07 [ 0.53, 8.13 ]
Total (95% CI) 134 139 100.0 % 2.07 [ 0.53, 8.13 ]
Total events: 6 (Induction), 3 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.05 (P = 0.29)
Test for subgroup differences: Not applicable
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WH A T ’ S N E W
Last assessed as up-to-date: 31 January 2016.
Date Event Description
23 May 2016 Amended Edited the plain language summary to include links to visual summaries (infographics) for this review
H I S T O R Y
Protocol first published: Issue 1, 1998
Review first published: Issue 2, 1998
Date Event Description
31 January 2016 New search has been performed Search updated. We have included one new trial and
this updated review is now comprised of four studies
(involving 1190 women)
31 January 2016 New citation required and conclusions have changed A large high-quality trial has now been included
(Boulvain 2015). Although no brachial plexus injuries
occurred, the inclusion of other data from that trial
means that the review now shows a reduction in birth
fractures and shoulder dystocia and suggests that there
is no overall increase in caesarean section
14 January 2011 New search has been performed Search updated. No new reports identified.
24 July 2009 New search has been performed Search updated. No new reports identified.
11 February 2008 Amended Converted to new review format.
30 September 2007 New search has been performed Search updated. A previously identified ongoing study
has been completed (LIBBY 1998) and we have in-
cluded the results in this update. The review’s conclu-
sions have not changed
31 July 2004 New search has been performed New search undertaken, as a result of which we have
identified two new ongoing studies. We have also
added a Synopsis
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C O N T R I B U T I O N S O F A U T H O R S
Olivier Irion and Michel Boulvain wrote the protocol, collected the data and contributed to writing this updated review. Jim Thornton
collected the data and contributed to writing this update. Therese Dowswell collected the data and contributed to writing this update.
D E C L A R A T I O N S O F I N T E R E S T
Two of authors (MB and OI) are on one of the included trials (Boulvain 2015) and a third (JT) on another (LIBBY 1998). They
were not involved in carrying out data extraction or assessing risk of bias for their own trials. Data extraction and assessment of risk of
bias was for these trials was carried out by Leanne Jones and Therese Dowswell, Research Associates in the Cochrane Pregnancy and
Childbirth Group.
Michel Boulvain was an invited speaker at a DIP congress on gestational diabetes and received accommodation expenses.
Therese Dowswell is employed by the University of Liverpool on an NIHR Cochrane Programme Grant (13/89/05) to work on a range
of Cochrane Reviews. In the past 3 years her institution has received a grant from WHO to support her working on other Cochrane
reviews. The Funders have no influence on the content or conclusions of the relevant Cochrane reviews.
Olivier Irion receives salary support from the University Hospitals of Geneva and the University of Geneva. He has received money to
provide expert (extra-) judiciary reports unrelated to this review. He has also been refunded for travel and meetings fees by his institution
and the Swiss Ob-Gyn society and received payment from the University of Geneva for teaching (around 6 hours per year) on courses
provided to the Geneva Midwives school.
S O U R C E S O F S U P P O R T
Internal sources
• University of Geneva, Switzerland.
External sources
• National Institute for Health Research (NIHR), UK.
NIHR Cochrane Programme Grant Project: 13/89/05 - Pregnancy and childbirth systematic reviews to support clinical guidelines
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
The methods have been updated in accordance with the current standard methods for Cochrane Pregnancy and Childbirth Group.
Methods/outcomes - we have separated our outcomes into primary and secondary outcomes. We have also revised our list of outcomes.
In the earlier version of this review the list of outcomes was as follows.
• Maternal outcomes - proportion of women having caesarean section; instrumental delivery and spontaneous delivery.
• Perinatal outcomes - shoulder dystocia; brachial plexus injury; clavicular fracture; intracranial haemorrhage, diagnosed by
sonography.
For this update, we have specified the following outcomes.
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Primary outcomes
Maternal outcomes
• Caesarean section
• Instrumental delivery
Perinatal outcomes
• Shoulder dystocia
• Brachial plexus injury
• Fracture (any)
• Neonatal asphyxia (low arterial cord blood pH, or low five-minute Apgar score)
Secondary outcomes
Maternal outcomes
• Spontaneous delivery
• Third- and fourth-degree perineal tears
• Maternal dissatisfaction (pain, sexual dysfunction)
Perinatal outcomes
• Mean birthweight (g)
• Admission to neonatal intensive care unit
• Intracranial haemorrhage
• Convulsions
• Perinatal mortality
• Long-term disability in childhood
We have also reported findings for the following non pre-specified outcomes.
• Significant shoulder dystocia (trialist defined)
• Serious neonatal morbidity or death (composite outcome)
• Use of phototherapy
• Cephalohematoma
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Fetal Macrosomia; ∗Labor, Induced; BirthWeight; Brachial PlexusNeuropathies [prevention & control]; Delivery,Obstetric; Dystocia
[prevention & control]; Obstetric Labor Complications [prevention & control]; Randomized Controlled Trials as Topic; Watchful
Waiting
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MeSH check words
Female; Humans; Pregnancy
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